K E Wallner
Overview
Explore the profile of K E Wallner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
724
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rahman R, Clark M, Collins Z, Traore F, Dioukhane E, Thiam H, et al.
Glob Health Action
. 2019 Apr;
12(1):1587894.
PMID: 30938248
Background: Worldwide, nearly 570,000 women are diagnosed with cervical cancer each year, with 85% of new cases in low- and middle-income countries. The African continent is home to 35 of...
2.
Taira A, Merrick G, Galbreath R, Andreini H, Taubenslag W, Curtis R, et al.
Prostate Cancer Prostatic Dis
. 2009 Sep;
13(1):71-7.
PMID: 19786982
Transrectal ultrasound (TRUS) biopsy can miss 20-30% of clinically significant cancers. We evaluate an alternative approach-transperineal template-guided mapping biopsy (TTMB) in the initial and repeat biopsy setting. From January 2005...
3.
Han B, Wallner K
Int J Cancer
. 2001 Dec;
96(6):372-8.
PMID: 11745508
Despite rates of radiation proctitis reported in the 1% to 9% range in most series, there is little information regarding rectal morbidity and dosimetric parameters. Accordingly, we have analyzed computed...
4.
Zelefsky M, Hollister T, Raben A, Matthews S, Wallner K
Int J Radiat Oncol Biol Phys
. 2000 Jul;
47(5):1261-6.
PMID: 10889379
Purpose: To report the 5-year prostate-specific antigen (PSA) relapse-free survival outcome and incidence of long-term morbidity for patients with localized prostate cancer treated with CT-planned permanent I-125 prostate implantation using...
5.
Zelefsky M, Wallner K, Ling C, Raben A, Hollister T, Wolfe T, et al.
J Clin Oncol
. 1999 Mar;
17(2):517-22.
PMID: 10080594
Purpose: To compare the prostate-specific antigen (PSA) relapse-free survival outcome and incidence of late toxicity for patients with early-stage prostate cancer treated at a single institution with either three-dimensional conformal...
6.
Blasko J, Wallner K, Cavanagh W
Cancer J Sci Am
. 1998 Jun;
4(3):157-8.
PMID: 9612595
No abstract available.
7.
Zelefsky M, Leibel S, Wallner K, WHITMORE Jr W, Fuks Z
J Clin Oncol
. 1995 Feb;
13(2):459-63.
PMID: 7531221
Purpose: To determine the prognostic significance of a normal serum prostate-specific antigen (PSA) level in patients with prostatic cancer with long-term follow-up evaluation after radiotherapy. Materials And Methods: PSA information...
8.
Zelefsky M, WHITMORE Jr W, Leibel S, Wallner K, Fuks Z
J Urol
. 1993 Dec;
150(6):1860-4.
PMID: 8230519
Between March 1970 and December 1987, 1,078 patients with adenocarcinoma of the prostate were treated with pelvic lymph node dissection and permanent 125iodine implantation. Before implantation, 257 patients (27%) underwent...
9.
Roy J, Anderson L, Wallner K, Fuks Z, Ling C
Radiother Oncol
. 1993 Jul;
28(1):72-5.
PMID: 8234873
The tumor control probabilities (TCPs) for 11 transperineal permanent implants of the prostate with 125I seeds have been computed, based on target-specific volume-dose histogram data. Prostate dose-response of this modality...
10.
Roy J, Wallner K, Harrington P, Ling C, Anderson L
Int J Radiat Oncol Biol Phys
. 1993 Apr;
26(1):163-9.
PMID: 8482623
A computerized tomography-based 3-dimensional evaluation scheme, using semi-automatic seed localization from transverse computerized tomography-images, has been developed for permanent implants. The treatment isodose contour is generated at each scan plane...